180 related articles for article (PubMed ID: 36321807)
1. Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta.
Shi C; Sun B; Wu H; Zhang R; Wu L; Guo L; Li C; Xi Y; Yuan W; Zhang Y; Xu G
J Bone Miner Res; 2023 Jan; 38(1):103-118. PubMed ID: 36321807
[TBL] [Abstract][Full Text] [Related]
2. Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta.
Sun B; Wu H; Lu J; Zhang R; Shen X; Gu Y; Shi C; Zhang Y; Yuan W
J Orthop Translat; 2023 Jan; 38():175-189. PubMed ID: 36439629
[TBL] [Abstract][Full Text] [Related]
3. Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta.
Shi C; Hu B; Guo L; Cao P; Tian Y; Ma J; Chen Y; Wu H; Hu J; Deng L; Zhang Y; Yuan W
J Bone Miner Res; 2016 May; 31(5):1003-14. PubMed ID: 26679066
[TBL] [Abstract][Full Text] [Related]
4. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
[TBL] [Abstract][Full Text] [Related]
5. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
6. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Cardinal M; Dessain A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Calcif Tissue Int; 2020 May; 106(5):494-508. PubMed ID: 32025752
[TBL] [Abstract][Full Text] [Related]
8. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
Berman AG; Wallace JM; Bart ZR; Allen MR
Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
[TBL] [Abstract][Full Text] [Related]
10. Intrafibrillar mineralization deficiency and osteogenesis imperfecta mouse bone fragility.
Maghsoudi-Ganjeh M; Samuel J; Ahsan AS; Wang X; Zeng X
J Mech Behav Biomed Mater; 2021 May; 117():104377. PubMed ID: 33636677
[TBL] [Abstract][Full Text] [Related]
11. Neurocranial growth in the OIM mouse model of osteogenesis imperfecta.
Husain TS; Moore JC; Huston LA; Miller CA; Steele AT; Gonzales LA; Handler EK; Organ JM; Menegaz RA
Anat Rec (Hoboken); 2024 Mar; 307(3):581-591. PubMed ID: 37638403
[TBL] [Abstract][Full Text] [Related]
12. Internalization of the TGF-β type I receptor into caveolin-1 and EEA1 double-positive early endosomes.
He K; Yan X; Li N; Dang S; Xu L; Zhao B; Li Z; Lv Z; Fang X; Zhang Y; Chen YG
Cell Res; 2015 Jun; 25(6):738-52. PubMed ID: 25998683
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin Promotes Osteogenesis through TGF-β Receptor II Binding in Osteoblasts and Activation of Canonical TGF-β Signaling in MC3T3-E1 Cells and C57BL/6J Mice.
Li Y; Wang J; Ren F; Zhang W; Zhang H; Zhao L; Zhang M; Cui W; Wang X; Guo H
J Nutr; 2018 Aug; 148(8):1285-1292. PubMed ID: 29931165
[TBL] [Abstract][Full Text] [Related]
14. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
15. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
[TBL] [Abstract][Full Text] [Related]
16. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.
Zhao B; Wang Q; Du J; Luo S; Xia J; Chen YG
Cell Res; 2012 Oct; 22(10):1467-78. PubMed ID: 22710801
[TBL] [Abstract][Full Text] [Related]
17. The type II TGF-β receptor phosphorylates Tyr
Yakymovych I; Yakymovych M; Hamidi A; Landström M; Heldin CH
Sci Signal; 2022 Nov; 15(760):eabp9521. PubMed ID: 36378749
[TBL] [Abstract][Full Text] [Related]
18. Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.
Jeong Y; Daghlas SA; Kahveci AS; Salamango D; Gentry BA; Brown M; Rector RS; Pearsall RS; Phillips CL
Muscle Nerve; 2018 Feb; 57(2):294-304. PubMed ID: 28555931
[TBL] [Abstract][Full Text] [Related]
19. Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta.
Tauer JT; Abdullah S; Rauch F
J Bone Miner Res; 2019 Feb; 34(2):207-214. PubMed ID: 30357929
[TBL] [Abstract][Full Text] [Related]
20. Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta.
Grafe I; Yang T; Alexander S; Homan EP; Lietman C; Jiang MM; Bertin T; Munivez E; Chen Y; Dawson B; Ishikawa Y; Weis MA; Sampath TK; Ambrose C; Eyre D; Bächinger HP; Lee B
Nat Med; 2014 Jun; 20(6):670-5. PubMed ID: 24793237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
